Skip to content

Whole Blood Biospecimen Collection for Subjects With Fanconi Anemia

Whole Blood Biospecimen Collection for Subjects With Fanconi Anemia

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05910853
Enrollment
4
Registered
2023-06-20
Start date
2023-05-24
Completion date
2024-03-12
Last updated
2024-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fanconi Anemia

Brief summary

The primary study objective is to collect biospecimen samples (e.g., blood) from participants diagnosed with Fanconi Anemia. The biospecimens will be used to create a biorepository that can be used to identify disease associated biomarkers and potential targets with immune and multi-omics profiling. The disease sample collection and analysis will be the foundation for an extensive network of biospecimen access and linked datasets for future translational research.

Interventions

DIAGNOSTIC_TESTSpecimen Donation

Blood donation

Sponsors

Sanguine Biosciences
Lead SponsorINDUSTRY

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* The participant is willing and able to provide written informed consent * The participant is willing and able to provide appropriate photo identification * Participants aged 18 to 85 * Participants have been diagnosed with Fanconi Anemia complementation group A

Exclusion criteria

* Participants who are pregnant or are nursing * Participants with a known history of HIV, hepatitis, or other infectious diseases Participants who have taken an investigational product in the last 30 days Participants who have experienced excess blood loss, including blood donation, defined as 250 mL in the last month or 500 mL in the previous two months

Design outcomes

Primary

MeasureTime frameDescription
Biospecimen Samples collect from patients with Fanconi Anemia participants diagnosed with Fanconi Anemia.1 yearThe primary study objective is to collect biospecimen samples (e.g., blood) from participants diagnosed with Fanconi Anemia. The biospecimens will be used to create a biorepository that can be used to identify disease associated biomarkers and potential targets with immune and multi-omics profiling. The disease sample collection and analysis will be the foundation for an extensive network of biospecimen access and linked datasets for future translational research.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026